Patent 10995424 was granted and assigned to Inscripta on May, 2021 by the United States Patent and Trademark Office.
The present disclosure provides shuttle vectors for editing exogenous polynucleotides in heterologous live cells, as well as automated methods, modules, and multi-module cell editing instruments and systems for performing the editing methods.